Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-13 Sale | 2023-09-14 4:14 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 6,411 | $1.3257 | $8,499 | 249,559 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:26 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 12,663 | $0.5978 | $7,570 | 214,848 (Direct) | View |
| 2022-07-19 Sale | 2022-07-20 4:06 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 4,289 | $1.1 | $4,718 | 107,511 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-10 Disposition | 2023-10-11 10:05 am | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 90,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:05 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 369,559 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:05 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 120,000 | $0 | 0 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:14 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 22,200 | $0 | 249,559 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:20 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 5,145 | $0.5965 | 233,770 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:20 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 14,926 | $0 | 233,770 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 4,809 | $0.5952 | 223,989 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 13,950 | $0 | 223,989 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:26 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 120,000 | $0 | 214,848 (Direct) | View |
| 2022-07-18 Option Award | 2022-07-20 4:06 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 14,800 | $0 | 107,511 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:16 pm | N/A 2032-01-26 | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 150,000 | $0 | 187,000 (Direct) | View |
| 2021-01-21 Option Award | 2021-01-25 4:15 pm | N/A 2031-01-21 | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 92,000 | $0 | 92,000 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-03 4:35 pm | N/A 2030-01-30 | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 58,000 | $0 | 58,000 (Direct) | View |